Voltaren is a brand name for the non-steroidal anti-inflammatory drug diclofenac. It exerts its pharmacological action by inhibiting the synthesis of prostaglandins in inflamed tissues. The medication is formulated for topical application or oral delivery depending on the dosage form. Inhibiting prostaglandin production reduces inflammation pain and fever by decreasing the activity of cyclooxygenase enzymes. Through systemic or local absorption the drug interacts with cellular pathways that regulate neurotransmitter release and nociceptor activation. The mechanistic effect includes modulation of endothelial adhesion molecules that contribute to tissue swelling. This targeted action provides analgesia and anti-inflammatory benefits directly at the site of injury. The overall therapeutic purpose is to restore normal physiological function by attenuating the inflammatory cascade.

Voltaren is a brand name for a formulation containing diclofenac a nonsteroidal anti-inflammatory drug. It is classified as an analgesic and anti-inflammatory medication used to relieve pain and inflammation. The drug works by inhibiting the cyclooxygenase enzymes cox 1 and cox 2 which reduces the production of prostaglandins at sites of tissue injury. By decreasing prostaglandin levels the medication diminishes fever swelling and the sensation of pain in the affected area. This pharmacological activity makes Voltaren effective for conditions such as osteoarthritis rheumatoid arthritis and postoperative dental pain. Its systemic absorption allows the agent to reach inflamed tissues throughout the body after oral administration or topical application. The sustained suppression of inflammatory mediators provides longer lasting symptom control compared with short acting alternatives.

The most common side effects often include mild headache and temporary fatigue. These reactions are generally short lived and do not require intervention. Nausea is another frequently reported symptom that may occur early in treatment. Some individuals notice slight dizziness that resolves as the body adjusts. Skin irritation can appear at application sites when a topical agent is used. Overall the frequency of these effects remains low across the population.

The most common side effects often involve mild discomfort in the treated area. Headache may appear temporarily alongside other sensations. Nausea is sometimes reported especially after certain procedures. Fatigue can be experienced when activity levels are reduced. Skin irritation may develop near the site of intervention. Dizziness sometimes occurs during rapid changes in posture. Most symptoms subside within a short period without additional intervention.